Sobi - Swedish Orphan Biovitrum AB (publ)

Specialty care Launch Lead

Sobi - Swedish Orphan Biovitrum AB (publ)  •  Prague, CZ (Onsite)  •  2 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come from a variety of backgrounds within research, healthcare, industry and the academic sphere.

The Specialty care Launch Lead, International is responsible for launch readiness and cross-regional pre-launch activities across the International region, with a clear focus on accelerating appropriate patient identification and uptake in alignment with Sobi’s mission to improve the lives of people living with FSC/sTGH. You will drive cross-functional execution across Commercial, Medical and Market Access, as well as external partners, to enable timely and compliant adoption of diagnostic pathways and pre-launch engagement. You will establish scalable frameworks and performance metrics that translate scientific insights into actionable plans—while upholding high ethical standards and patient-centricity.

Key responsibilities

  • Lead end-to-end International launch planning and execution—from disease awareness to patient identification, referral and appropriate next steps—adapting to country-specific requirements.
  • Identify key barriers and risks to launch success, design mitigation plans and track impact across markets.
  • Develop stakeholder segmentation and engagement strategies across HCPs, payers and patient organisations, ensuring fair-balanced, compliant materials and interactions.
  • Partner closely with Medical Affairs to align scientific narrative, medical education and data-generation priorities; capture and synthesise field insights to refine strategy and tactics.
  • Collaborate with Market Access to shape evidence needs and value messaging that support reimbursement and (where relevant) funding of diagnostic services.
  • Enable affiliates/partners through launch toolkits, capability building, training and readiness milestones; ensure consistent measurement and ways of working.
  • Define and run KPIs and dashboards (e.g., diagnostic access, time-to-diagnosis, referral conversion, stakeholder reach/engagement quality) and drive continuous improvement.
  • Manage external vendors/partners delivering cross-regional programmes and disease awareness initiatives; ensure cost-effective, high-quality and compliant execution.
  • Operate within all applicable laws, industry codes and Sobi policies, maintaining strong integrity, data privacy and non-promotional conduct.

Qualifications

  • 8+ years of commercial and launch experience (local and international/global), ideally in metabolic and/or dyslipidaemia disease areas.
  • Demonstrated track record of international launch planning and execution in a matrix environment.
  • Experience building patient identification and referral approaches (e.g., diagnostic pathway development, disease awareness programmes, field enablement).
  • Strong stakeholder management and cross-functional collaboration; ability to translate scientific insights into actionable plans and measurable outcomes.
  • Excellent communication skills and scientific literacy; confident working with Medical Affairs and external experts.
  • Fluent English; additional languages are an advantage.

Additional Information

All your information will be kept confidential according to EEO guidelines.

Sobi - Swedish Orphan Biovitrum AB (publ)

About Sobi - Swedish Orphan Biovitrum AB (publ)

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.

We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life.

Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at  sobi.com and LinkedIn.

Industry
Chemicals & Materials
Company Size
1,001-5,000 employees
Headquarters
Stockholm, SE
Year Founded
Unknown
Website
sobi.com
Social Media